A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 31/47 (2006.01) A61K 31/4709 (2006.01) A61K 31/517 (2006.01) A61K 31/519 (2006.01) A61K 39/395 (2006.01) A61P 1/00 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2575541
The present invention relates to novel pharmaceutical compositions comprising at least one EGFR kinase inhibitor and at least one additional active compound selected from beta-2 mimetics, steroids, PDE-IV inhibitors, p38 MAP kinase inhibitors, NK1 antagonists and endothelin-antagonists, processes for preparing the compositions and the use thereof as medicament in the treatment of respiratory or gastrointestinal complaints, as well as inflammatory diseases of the joints, the skin or the eyes.
La présente invention concerne des nouvelles compositions pharmaceutiques comprenant au moins un inhibiteur de EGFR kinase et au moins un composé actif supplémentaire choisi parmi des mimétiques de bêta-2, des stéroïdes, des inhibiteurs de PDE-IV, des inhibiteurs de p38 MAP kinase, des antagonistes de NK1 et des antagonistes d'endothéline, des procédés pour préparer les compositions et l'utilisation de celles-ci en tant que médicament dans le traitement de troubles respiratoires et gastro-intestinaux, ainsi que de maladies inflammatoires des articulations, de la peau ou des yeux.
Himmelsbach Frank
Jung Birgit
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
New pharmaceutical compositions for treatment of respiratory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New pharmaceutical compositions for treatment of respiratory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New pharmaceutical compositions for treatment of respiratory... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1875566